Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no other substantive content changes observed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding information about renal cell carcinoma and cabozantinib, while removing previous location terms and a specific version reference.SummaryDifference1%
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.11, replacing the previous version v2.16.10. The phrasing for the last update has also changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated with new dates and a revision number, indicating a recent update to the content. The previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.